PROCEPT BioRobotics (PRCT) Competitors $40.17 -0.17 (-0.42%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$40.73 +0.56 (+1.39%) As of 08/29/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRCT vs. STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, and INSPShould you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. PROCEPT BioRobotics vs. Its Competitors Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems Stevanato Group (NYSE:STVN) and PROCEPT BioRobotics (NASDAQ:PRCT) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Is STVN or PRCT more profitable? Stevanato Group has a net margin of 11.73% compared to PROCEPT BioRobotics' net margin of -30.60%. Stevanato Group's return on equity of 10.34% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group11.73% 10.34% 6.21% PROCEPT BioRobotics -30.60%-23.73%-17.34% Do analysts recommend STVN or PRCT? PROCEPT BioRobotics has a consensus target price of $74.88, suggesting a potential upside of 86.40%. Given PROCEPT BioRobotics' higher possible upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83PROCEPT BioRobotics 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78 Does the media prefer STVN or PRCT? In the previous week, PROCEPT BioRobotics had 11 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for PROCEPT BioRobotics and 6 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.56 beat PROCEPT BioRobotics' score of 1.47 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive PROCEPT BioRobotics 15 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, STVN or PRCT? Stevanato Group has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group€1.15B6.12€127.45M€0.5442.85PROCEPT BioRobotics$274.95M8.13-$91.41M-$1.55-25.92 Which has more risk & volatility, STVN or PRCT? Stevanato Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Do institutionals and insiders hold more shares of STVN or PRCT? 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 6.6% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryStevanato Group beats PROCEPT BioRobotics on 10 of the 17 factors compared between the two stocks. Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRCT vs. The Competition Export to ExcelMetricPROCEPT BioRoboticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.24B$6.99B$5.66B$9.84BDividend YieldN/A1.20%3.93%4.04%P/E Ratio-25.9226.1883.2726.61Price / Sales8.1364.28451.26176.28Price / CashN/A21.6837.7059.65Price / Book5.807.0910.556.59Net Income-$91.41M$176.42M$3.27B$266.12M7 Day Performance-2.57%0.83%0.42%0.17%1 Month Performance-21.77%1.43%5.91%3.02%1 Year Performance-49.15%6.64%48.11%19.69% PROCEPT BioRobotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRCTPROCEPT BioRobotics3.485 of 5 stars$40.17-0.4%$74.88+86.4%-49.0%$2.24B$274.95M-25.92430Positive NewsSTVNStevanato Group3.0419 of 5 stars€21.99-2.8%N/A+7.2%€6.66B€1.19B40.725,521News CoveragePositive NewsIRTCiRhythm Technologies1.2873 of 5 stars$165.68-2.0%$162.64-1.8%+134.7%$5.43B$591.84M0.002,000Positive NewsAnalyst ForecastGKOSGlaukos4.6749 of 5 stars$91.78-2.5%$127.42+38.8%-27.7%$5.40B$383.48M-55.62780News CoverageBLCOBausch + Lomb1.1442 of 5 stars$14.57-2.5%$15.56+6.8%-8.6%$5.29B$4.79B35.5713,500TMDXTransMedics Group3.3032 of 5 stars$114.97-4.1%$123.00+7.0%-31.0%$4.09B$441.54M62.10210News CoveragePositive NewsAnalyst DowngradeSLNOSoleno Therapeutics4.5063 of 5 stars$66.51-3.0%$115.09+73.0%+45.3%$3.64BN/A-16.0730News CoverageAnalyst ForecastNVSTEnvista3.8807 of 5 stars$21.15-2.6%$20.92-1.1%+14.9%$3.61B$2.51B25.2612,300News CoveragePositive NewsAnalyst DowngradeLIVNLivaNova1.5632 of 5 stars$56.35+0.8%$59.71+6.0%+12.2%$3.05B$1.25B-14.492,900Positive NewsWRBYWarby Parker2.0947 of 5 stars$26.18-3.1%$24.06-8.1%+74.8%$2.84B$771.32M-373.883,780News CoveragePositive NewsAnalyst UpgradeINSPInspire Medical Systems4.9821 of 5 stars$93.20-2.9%$165.62+77.7%-48.8%$2.84B$802.80M41.741,246Positive News Related Companies and Tools Related Companies STVN Competitors IRTC Competitors GKOS Competitors BLCO Competitors TMDX Competitors SLNO Competitors NVST Competitors LIVN Competitors WRBY Competitors INSP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRCT) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRCT Stock Alerts